Patient-Funded Trials: Opportunity or Liability?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26253199.
- Also identified by DOI 10.1016/j.stem.2015.07.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patient-funded trials (PFTs) are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols.
Medical subject headings
- Clinical Trials as Topic